247 related articles for article (PubMed ID: 19560513)
1. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease.
Solomon A; Leoni V; Kivipelto M; Besga A; Oksengård AR; Julin P; Svensson L; Wahlund LO; Andreasen N; Winblad B; Soininen H; Björkhem I
Neurosci Lett; 2009 Oct; 462(1):89-93. PubMed ID: 19560513
[TBL] [Abstract][Full Text] [Related]
2. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.
Vega GL; Weiner M; Kölsch H; von Bergmann K; Heun R; Lutjohan D; Nguyen A; Moore C
Curr Alzheimer Res; 2004 Feb; 1(1):71-7. PubMed ID: 15975088
[TBL] [Abstract][Full Text] [Related]
3. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
Vega GL; Weiner MF; Lipton AM; Von Bergmann K; Lutjohann D; Moore C; Svetlik D
Arch Neurol; 2003 Apr; 60(4):510-5. PubMed ID: 12707064
[TBL] [Abstract][Full Text] [Related]
4. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.
Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Rao ML; Maier W; Björkhem I; von Bergmann K; Heun R
Neuroreport; 2000 Jun; 11(9):1959-62. PubMed ID: 10884051
[TBL] [Abstract][Full Text] [Related]
5. Oxysterols as biomarkers in neurodegenerative diseases.
Leoni V; Caccia C
Chem Phys Lipids; 2011 Sep; 164(6):515-24. PubMed ID: 21515244
[TBL] [Abstract][Full Text] [Related]
6. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.
Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Buschfort R; Ptok U; Björkhem I; von Bergmann K; Heun R
J Psychiatr Res; 2002; 36(1):27-32. PubMed ID: 11755458
[TBL] [Abstract][Full Text] [Related]
7. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.
Lütjohann D; Papassotiropoulos A; Björkhem I; Locatelli S; Bagli M; Oehring RD; Schlegel U; Jessen F; Rao ML; von Bergmann K; Heun R
J Lipid Res; 2000 Feb; 41(2):195-8. PubMed ID: 10681402
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls.
Schönknecht P; Lütjohann D; Pantel J; Bardenheuer H; Hartmann T; von Bergmann K; Beyreuther K; Schröder J
Neurosci Lett; 2002 May; 324(1):83-5. PubMed ID: 11983301
[TBL] [Abstract][Full Text] [Related]
9. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
Lütjohann D; von Bergmann K
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
[TBL] [Abstract][Full Text] [Related]
10. Alterations of cholesterol precursor levels in Alzheimer's disease.
Kölsch H; Heun R; Jessen F; Popp J; Hentschel F; Maier W; Lütjohann D
Biochim Biophys Acta; 2010 Aug; 1801(8):945-50. PubMed ID: 20226877
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health.
Leoni V; Solomon A; Lövgren-Sandblom A; Minthon L; Blennow K; Hansson O; Wahlund LO; Kivipelto M; Björkhem I
J Alzheimers Dis; 2013; 36(4):739-47. PubMed ID: 23666171
[TBL] [Abstract][Full Text] [Related]
12. Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease.
Popp J; Meichsner S; Kölsch H; Lewczuk P; Maier W; Kornhuber J; Jessen F; Lütjohann D
Biochem Pharmacol; 2013 Jul; 86(1):37-42. PubMed ID: 23291240
[TBL] [Abstract][Full Text] [Related]
13. Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients.
Kölsch H; Heun R; Kerksiek A; Bergmann KV; Maier W; Lütjohann D
Neurosci Lett; 2004 Sep; 368(3):303-8. PubMed ID: 15364416
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic use of cerebral and extracerebral oxysterols.
Leoni V; Masterman T; Mousavi FS; Wretlind B; Wahlund LO; Diczfalusy U; Hillert J; Björkhem I
Clin Chem Lab Med; 2004 Feb; 42(2):186-91. PubMed ID: 15061359
[TBL] [Abstract][Full Text] [Related]
15. Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms.
Vega GL; Weiner MF
J Mol Neurosci; 2007 Sep; 33(1):51-5. PubMed ID: 17901546
[TBL] [Abstract][Full Text] [Related]
16. Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment?
Leoni V; Shafaati M; Salomon A; Kivipelto M; Björkhem I; Wahlund LO
Neurosci Lett; 2006 Apr 10-17; 397(1-2):83-7. PubMed ID: 16406316
[TBL] [Abstract][Full Text] [Related]
17. Potential diagnostic applications of side chain oxysterols analysis in plasma and cerebrospinal fluid.
Leoni V; Caccia C
Biochem Pharmacol; 2013 Jul; 86(1):26-36. PubMed ID: 23541982
[TBL] [Abstract][Full Text] [Related]
18. Correlations between cerebellar and brain volumes, cognitive impairments, ApoE levels, and APOE genotypes in patients with AD and MCI.
Łojkowska W; Witkowski G; Bednarska-Makaruk M; Wehr H; Sienkiewicz-Jarosz H; Graban A; Bochyńska A; Wiśniewska A; Gugała M; Sławińska K; Sawicka B; Poniatowska R; Ryglewicz D
Curr Alzheimer Res; 2013 Nov; 10(9):964-72. PubMed ID: 24117117
[TBL] [Abstract][Full Text] [Related]
19. Links between ApoE, brain cholesterol metabolism, tau and amyloid beta-peptide in patients with cognitive impairment.
Leoni V; Solomon A; Kivipelto M
Biochem Soc Trans; 2010 Aug; 38(4):1021-5. PubMed ID: 20658997
[TBL] [Abstract][Full Text] [Related]
20. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain.
Locatelli S; Lütjohann D; Schmidt HH; Otto C; Beisiegel U; von Bergmann K
Arch Neurol; 2002 Feb; 59(2):213-6. PubMed ID: 11843691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
